Malignant neoplasm of prostate (C61)

The ICD-10 code C61 is used to identify malignant neoplasm of the prostate, or in simpler terms, prostate cancer. This code helps healthcare providers and coders classify tumors that originate in the prostate gland and its surrounding tissues.

C61 covers various forms of prostate cancer, including common and specific types like adenocarcinoma of the prostate, squamous cell carcinoma, and primary acinar cell cystadenocarcinoma. Synonyms such as "carcinoma of prostate," "primary malignant neoplasm of prostate," and "hormone refractory prostate cancer" are included to help clarify that all these terms fall under this single diagnostic code. Additionally, this code applies to prostate cancer that may extend into nearby organs like the seminal vesicles, urethra, or bladder. The ICD-10 code for malignant neoplasm of the prostate is essential for accurately documenting prostate cancer diagnoses, especially when dealing with localized, recurrent, or metastatic forms, including hormone-sensitive and castration-resistant variants.

Instructional Notations

Use Additional Code

The “use additional code” indicates that a secondary code could be used to further specify the patient’s condition. This note is not mandatory and is only used if enough information is available to assign an additional code.

  • code, if applicable, to identify:
  • hormone sensitivity status Z19.1 Z19.2
  • rising PSA following treatment for malignant neoplasm of prostate R97.21

Type 1 Excludes

A type 1 excludes note is a pure excludes note. It means "NOT CODED HERE!" An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.

  • malignant neoplasm of seminal vesicle C63.7